Latigo Biotherapeutics
$13.00
2
-$0.95-6.8% 09:00 Today
Statistics
Day High
13.97
Day Low
13.91
52W High
25.93
52W Low
13.5
Volume
15,292
Avg. Volume
-
Mkt Cap
924.88M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Dec 2Expected
Q2 2026
Next
-0.63
-0.57
-0.51
-0.46
Expected EPS
-0.62565
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-109.17MNet Income
Analyst Ratings
$45.33Average Price Target
The highest estimate is 50.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow LTGO. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.
Show More
CEO
Nima Farzan
Employees
59
Country
United States
ISIN
US5179541033
Listings
0 Comments
Share your thoughts
FAQs
What is Latigo Biotherapeutics stock price today?▼
The current price of LTGO is $13.00 USD — it has decreased by -6.8% in the past 24 hours. Watch Latigo Biotherapeutics stock price performance more closely on the chart.
What is Latigo Biotherapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Latigo Biotherapeutics stocks are traded under the ticker LTGO.
What is Latigo Biotherapeutics market cap?▼
Today Latigo Biotherapeutics has the market capitalization of 924.88M
When is the next Latigo Biotherapeutics earnings date?▼
Latigo Biotherapeutics is going to release the next earnings report on December 2, 2026.
What were Latigo Biotherapeutics earnings last quarter?▼
LTGO earnings for the last quarter are -0.46 USD per share, whereas the estimation was -0.62 USD resulting in a +25.99% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Latigo Biotherapeutics revenue for the last year?▼
Latigo Biotherapeutics revenue for the last year amounts to 0 USD.
What is Latigo Biotherapeutics net income for the last year?▼
LTGO net income for the last year is -109.17M USD.
How many employees does Latigo Biotherapeutics have?▼
As of November 2, 2026, the company has 59 employees.
In which sector is Latigo Biotherapeutics located?▼
Latigo Biotherapeutics operates in the Health & Wellness sector.
When did Latigo Biotherapeutics complete a stock split?▼
Latigo Biotherapeutics has not had any recent stock splits.
Where is Latigo Biotherapeutics headquartered?▼
Latigo Biotherapeutics is headquartered in THOUSAND OAKS, United States.